Latest Advisories

  • FDA Advisory No. 2015-020 - A || Babala sa Publiko Tungkol sa Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot

  • FDA Advisory No. 2015-020 || Public Health Warning Against the Use of the Following Unregistered Products

  • FDA Advisory No. 2015-019 || Public Warning Against the Use of the following Unregistered Drug Products

  • FDA Advisory No. 2015-019-A || Babala sa Publiko Tungkol sa Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot

  • FDA Advisory No. 2015-018 || Termination of Product of Recall order issued on Specific Batches of Dobutamine (as Hydrochloride) 12.5 mg/mL (250 mg/20 mL) Solution for Injection (Dobulon)

     

New Schedule for the National Consultation for the Association of Southeast Asian
Nations (ASEAN) Traditional Medicines and Health Supplements (TMHS) Guidelines
Date : 05 January 2015 (Monday)
Time : 9:00 AM - 12:00 NN
Venue : 3rd Floor, Audio-Visual Bldg., FDA Compound
Civic Drive, Filinvest Corporate City,
Alabang Munlipa City
To continue reading download the attachment

In the interest of service, and for the information of all, the Food and Drug Administration (FDA) hereby adopts the Final Report of the 21 ASEAN Cosmetics Scientific Body (ACSB) and 21 ASEAN Cosmetic Committee (ACC) Correction in Annex III - Part I ref. No. 1a, column C point (b) "Products for all hygiene" to "Product for oral hygiene".

All company/ies or person/s responsible for placing the cosmetic product/s in the market are hereby advised to comply with this directive.

This order shall take effect immediately

SUBJECT : Administration of Customer Satisfaction Survey

In line with the intent to improve the FDA Services to its external and internal customers, there is a need to improve the collection of customer feedback

The FDA has established an administration of Customer Satisfaction Survey (CSS) to booth the internal and external FDA customers. A new color coded form will be used (white for external customers and green for internal customers), as well as new method  for administration and and collection will be instituted.

Effective 01 December 2014 the revised CSS form (see Annex A), together with the Visitor's ID pass, will be distributed by the Security Guards on duty to the external customers before entering FDA building. The accomplished survey form will be returned by the customers to the Security Guard on duty upon surrendering Visitor's ID pass.

For internal customers (FDA Employees) transacting business with the respective Centers and Offices, the accomplished CSS form shall be dropped in the box assigned per Center or Office. The accomplished CSS form shall be retrieved by the Policy and Planning Office at the end of each month.

For any question or clarification, please contact Policy and Planning Office at Telephone No. 857-1900 local 1111 or 1121 or via email (This email address is being protected from spambots. You need JavaScript enabled to view it.).

For strict compliance

Announcement

BAC ADVISORY NO. 2014-002
(ITB No. 14-019)

Construction of FDA Walkway, Waiting Shed, Steel Gate and Perimeter Fence

Subject : Re-Scheduled of PRE-BID CONFERENCE

09 December 2014

The PRE-BID CONFERENCE for the above subject project was not transpired on 08 December 2014 due to TYPHOON RUBY that caused work cancellation of all government offices in the National Capital Region (NCR).

In view thereof, all prospective bidders advised that the PRE-BID CONFERENCE is hereby re-scheduled on 11 December 2014 at 2:00pm, AFO Conference Room

For information and guidance of all concerned.

 

Announcement

  • Second Meeting on the Regulation of Finished Paint Products

    ANNOUNCEMENT

    To      : All Concerned Paint Stakeholders

    From    : Center for Cosmetics Regulation and Research (CCRR)

    Subject : Second Meeting on the Regulation of Finished Paint Products

    In the Interest of service, the Center for Cosmetics Regulation and Research (CCRR) shall conduct a second meeting on the regulation of finished paint products to further discuss regulatory measures involving household/urban hazardous substances (HUHS), particularly paint products, with the following details:

    Date : 27 March 2015
    Time : 1:00 PM
    Venue : CDRRHR (Formerly BHDT) Conference Room
               Building 24, Department of Health
               San Lazaro Compound, Rizal Avenue, Sta. Cruz, Manila

    All concerned paint stakeholders are invited to attend. Registration by e-mail at This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it. is on a first-come, first-serve basis and only twenty (20) participants (one representative per company) will be accommodated for this activity

    For your information and guidance.

  • Request for Rescheduling of Appointment/Submission

    ANNOUNCEMENT

    Date : 20 March 2015

    To : All FDA-Regulated Establishment Applying for License to Operate (LTO), Certificate of Product Registration (CPR), and Other Authorizations Following the Public Assistance, Information and Receiving (PAIR) Process.

    Subject : Request for Rescheduling of Appointment/Submission

    Effective 16 April 2015, request for rescheduling of appointment for the submission of License to Operate, Certificate of Product Registration, and Other Authorizations following the PAIR Process should be coursed thru the e-mail account: This email address is being protected from spambots. You need JavaScript enabled to view it. following the hereunder format -

    To : This email address is being protected from spambots. You need JavaScript enabled to view it.
    Subject : Rescheduling of Appointment, 14-digit DTN
    Body: Application type (initial, renewal,re-application, etc.); for renewal application, please indicate expiry/validity
    date of current LTO/CPR

    The PAIR Unit will grant request for another appointment schedule only once, thus, applicant companies are advised to prepare all requirement, i.e. documentary, technical and financial, before sending an e-mail request. Further, to avoid inconveniences and payment of surcharge, applicants are highly encouraged to file renewal application as prescribed by existing regulations.

    For your information, guidance and compliance

  • National Consultation for Adoptation and Implementation of the Association of Southeast Asian Nations (ASEAN) Traditional Medicines and Health Supplements (TMHS) Guidelines for Davao

    Due to flight availability, the national consultation to discuss the upcoming adoptation and implementation of the Association of Southeast Asian Nations (ASEAN) Traditional Medicines and Health Supplements (TMHS) Guidelines for Davao on 18 March 2015 is rescheduled from 9:00 AM to 12:00 NN to 1:00 PM - 4:00 PM.

    For more information kindly coordinate with Regional Filed Office XI

    For your information, guidance, and compliance

  • Scheduled Delay in Processing of Electronic Cosmetic Product Notification

    ANNOUNCEMENT

    TO : All Cosmetics Manufacturer, Traders, Distributors and other concerned parties
    DATE : 19 November 2014
    SUBJECT : Scheduled Delay in Processing of Electronic Cosmetic Product Notification
                                         (Cosmetic e-Notification)
  • QPIRA ID for Release

    ANNOUNCEMENT

    DATE        : 10 November 2014
    TO            : ALL REGISTERED QUALIFIED PERSON IN
    INDUSTRY REGULATORY AFFAIRS (QPIRA)
    FROM        :  ATTY. RONALD R. DE VEYRA, MBA, CESO VI
     Acting Deputy Director General - AFO
    SUBJECT   : QPIRA ID for Release

Videos

  • Win the War Against AMR

    The misuse of antibiotics is creating resistant "superbugs" that may leave you or your family without effective treatment the next time antibiotics are needed.

  • FDA Public Assistance Information and Receiving (PAIR) Video Tutorial

    A step by step guide to filing an application for a License to Operate or a Certificate of Product Registration.
    By: Nicole Melanie Molera

  • Dr. Kenneth Hartigan-Go on Responsible Pharmaceutical Manufacturing by Interphil

    Dr. Kenneth Hartigan-Go talks about importance of CGMP in manufacturing pharmaceutical products, bioequivalence, importance of adverse drug monitoring, and ethical marketing communications.

Share Us on

Submit to FacebookSubmit to Google BookmarksSubmit to Twitter